Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (MCL1) (N-Term) Peptide

Details for Product No. ABIN1382255
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Protein Name
Synonyms BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT, AW556805, mcl-1
Protein Region
N-Term
Origin
Human
(1), (1), (6), (1), (1), (1)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Catalog no. ABIN1382255
Quantity 0.05 mg
Price
77.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 16 amino acids near the amino terminus of human Mcl-1.
Human
Alternative Name Mcl-1
Research Area Cancer, Apoptosis/Necrosis
Application Notes Mcl-1 peptide is used for blocking the activity of Mcl-1.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Storage -20 °C
Expiry Date 12 months
Background publications Kozopas, Yang, Buchan et al.: "MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, Issue 8, pp. 3516-20, 1993 (PubMed).

Chu, Ng: "Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells." in: The Journal of biological chemistry, Vol. 279, Issue 52, pp. 54533-41, 2004 (PubMed).

Chu, Rajamanonmani, Li et al.: "Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein." in: The Journal of general virology, Vol. 86, Issue Pt 2, pp. 405-12, 2005 (PubMed).

Reactivities (1), (1), (6), (1), (1), (1)
back to top